EUVIMEDSkopri EUVIMED
Crossref

Early Magnetic Resonance Imaging and Single‐Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin‐1‐Specific Molecular and Liposome Probes

Alexis Patou, Tea Lukačević iD, Agnès Pallier, Julien Sobilo, Sandra Même, Éva Tóth iD, Sara Lacerda iD

ChemMedChem · 2026-11-26 · 21 (22)

DOI: 10.1002/cmdc.70566 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-11-13. Written by Alexis Patou and 6 co-authors. Institution: Centre de Biophysique Moléculaire, CNRS UPR4301, Université d'Orléans, Orléans, France. Major MEDLINE topics: Magnetic Resonance Imaging, Tomography, Emission-Computed, Single-Photon, Netrin-1, Breast Neoplasms. 49 references. Funded by: Ligue Contre le Cancer, Cancéropôle Grand Ouest, ITMO Cancer of Aviesan.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Specific tumor biomarkers visualization by molecular magnetic resonance imaging (MRI) enables early cancer detection before morphologic changes appear. Herein, we designed a peptide targeting moiety (GEVMPTLDMALFDWTDYEDLKP) for the extracellular emerging biomarker Netrin‐1, which was first conjugated to a DOTA‐like chelator ( G ). 111 In‐ G highlighted small tumors in an orthotopic murine model of triple‐negative metastatic breast cancer (4T1) by single‐photon emission computerized tomography (SPECT). Nevertheless, 111 In‐ G had very high kidney uptake which prevailed 24 h post‐injection. To prevent potential toxicity for MRI Gd‐analog, injected in higher dose due to MRI’s low sensibility, we developed a novel targeted liposome formulation, ( 111 In)‐Gd‐L G . Liposomes contain PEGylated phospholipids functionalized with the new targeting peptide and amphiphilic Gd 3+ / 111 In 3+ chelates enabling multimodal MRI and/or SPECT detection. The formulation was optimized and characterized by dynamic light scattering and 1 H relaxometry. In the same 4T1 murine model, ex vivo biodistribution evidenced significantly reduced liposomes kidney uptake (4 vs. 137%ID/g for 111 In‐Gd‐L G versus 111 In‐ G , 4 h post injection), retaining tumor detection capabilities. Successful in vivo MRI visualization of small tumors (

Subjects

MeSH terms (MEDLINE)

Magnetic Resonance ImagingTomography, Emission-Computed, Single-PhotonNetrin-1Breast NeoplasmsMolecular ProbesLiposomesAnimalsFemaleMiceIndium RadioisotopesMice, Inbred BALB CCell Line, TumorHumansTissue Distribution

Author keywords

Netrin‐1liposomemetastatic breast cancermolecular MRItargeted contrast agent

Substances

LiposomesNetrin-1Indium RadioisotopesMolecular Probes

Authors and institutions

  • Centre de Biophysique Moléculaire, CNRS UPR4301, Université d'Orléans, Orléans, France.
  • TAAM-In vivo Imaging Centre, MO2VING CNRS UAR44, Orléans, France.

ORCID profiles: Tea Lukačević, Éva Tóth, Sara Lacerda

Funding

  • Ligue Contre le Cancer
  • Cancéropôle Grand Ouest
  • ITMO Cancer of Aviesan

Cite

APA

Patou, A., Lukačević, T., Pallier, A., Sobilo, J., Même, S., Tóth, É., & Lacerda, S. (2026). Early Magnetic Resonance Imaging and Single‐Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin‐1‐Specific Molecular and Liposome Probes. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70566

Vancouver

Patou A, Lukačević T, Pallier A, Sobilo J, Même S, Tóth É, et al. Early Magnetic Resonance Imaging and Single‐Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin‐1‐Specific Molecular and Liposome Probes. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70566

BibTeX
@article{Patou2026,
  author = {Patou, Alexis and Lukačević, Tea and Pallier, Agnès and Sobilo, Julien and Même, Sandra and Tóth, Éva and Lacerda, Sara},
  title = {Early Magnetic Resonance Imaging and Single‐Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin‐1‐Specific Molecular and Liposome Probes},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {22},
  doi = {10.1002/cmdc.70566}
}
Start for free →